Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net income/(loss)	$ 404,914	$ (4,467,125)	$ (3,161,342)
Adjustment to reconcile net income/(loss) to net cash (used in) operating activities
Change in derivative liabilities	(4,410,241)	2,524,671
Interest expense from derivative instruments	405,216	456,750
Employee stock compensation	122,630	94,637
Provision for doubtful accounts	76,634	(4,830)	11,131
Depreciation and amortization	216,069	174,436
Changes in operating assets and liabilities
Accounts receivable	(1,364,149)	(46,819)
Prepaid expenses	(69,257)	(6,032)
Other current assets	(16,138)	0
Other assets	32,159	(409)
Accounts payable and accrued expenses	695,548	410,815
Patent settlement liability	(216,692)	(192,527)
Deferred revenue	3,981,425	(83,604)
Net cash (used in) operating activities	(141,882)	(1,140,037)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(67,674)	(107,844)
Net cash (used in) investing activities	(67,674)	(107,844)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable	(20,925)	0
Proceeds from revolving line of credit	200,000	800,000
Net cash provided by financing activities	179,075	800,000
Effect of exchange rate changes	(36,557)	(30,485)
Net (decrease) in cash and cash equivalents	(67,038)	(478,366)
Cash and cash equivalents at beginning of period	1,160,720	873,315	873,315
Cash and cash equivalents at end of period	1,093,682	394,949	1,160,720
Cash paid during the period for:
Income taxes	35,264	48,599
Interest	1,114,666	725,546
Restricted Stock [Member]
Non-cash transactions:
Restricted stock issuance	238,000	222,500
Notes Payable Issued for Existing Notes Payable [Member]
Non-cash transactions:
Debt conversion, Notes Issued	1,902,500	2,866,879
Promissory Notes Issued for Accrued Interest [Member]
Non-cash transactions:
Debt conversion, Notes Issued	$ 980,000	$ 529,000